ELV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient entry: price is below the key pivot (347.94) with bearish momentum still present, and recent guidance/news flow has been a headwind.", "Near-term setup looks more like \u201cstabilize/mean-revert\u201d than a clean uptrend; a break back above ~348 would improve the risk/reward, but at 339.79 the tape is still weak.", "Intellectia Proprietary Trading Signals\n- AI Stock Picker: No signal on given stock today.\n- SwingMax: No signal on given stock today."]
["Trend/Momentum: MACD histogram at -4.06 (below zero) indicates bearish momentum, though it is negatively contracting (selling pressure is easing, but not reversed).", "RSI(6) at 38.87: weak/near-oversold territory, consistent with a stock trying to bottom rather than trending higher.", "Moving averages: converging MAs suggest consolidation after a drop, not a confirmed bullish trend.", "Levels: price (339.79) is below Pivot 347.94 (bearish bias). First support S1 ~323.88 (next key downside area). Resistance R1 ~372 (first meaningful upside hurdle).", "Pattern stats provided: 70% odds point to slight weakness next day (-0.34%), deeper weakness next week (-4.85%), but a better 1-month rebound bias (+5.32%)\u2014supports \u201chold/avoid chasing\u201d rather than \u201cbuy now.\u201d"]
["Q4 2025 showed solid operational delivery: revenue +9.47% YoY and EPS +36.46% YoY (supports longer-term earnings power).", "Management reiterated longer-term growth focus (notably the market\u2019s attention to 2027 earnings growth commentary).", "Congress trading (last 90 days): 4 purchases and 0 sales, with large notional ($1.5M\u2013$5.0M; median ~$3.3M) \u2014 influential-flow signal skewed positive."]
has recently hit sector sentiment and valuations.", "Flow/positioning risk: hedge funds are net sellers, with selling up 135.25% over the last quarter."]
["Latest quarter: 2025/Q4.", "Revenue: $49.75B, +9.47% YoY (continued top-line growth, though reported as below some expectations in the news summary).", "Net income: $547M, +30.86% YoY (profit growth accelerated).", "EPS: $2.47, +36.46% YoY (strong per-share growth in the quarter).", "Key issue: despite Q4 growth, forward-year (2026) earnings guidance was guided lower/softer, which is weighing on the stock."]
["Recent trend: broad price-target trims after Q4/guidance (Truist 400\u2192390, Bernstein 431\u2192409, Barclays 404\u2192393, Wells 424\u2192391, UBS 425\u2192400, Guggenheim 414\u2192396), reflecting tempered near-term margin/rate assumptions.", "Notable action: RBC downgraded to Sector Perform (358 PT) citing softer 2026 guidance and limited reason to pay above long-term average valuation.", "Still constructive overall: multiple firms maintain Buy/Overweight/Outperform (JPM Overweight with 397 PT; others remain positive despite lowered targets).", "Wall Street pros: expectation of margin recovery and longer-term earnings growth path; targets still generally well above the current price (~340). Cons: near-term MA/Medicaid headwinds, rate pressure, and guidance-driven multiple compression risk."]
